Can Anything Stop Johnson & Johnson?

Shares of Johnson & Johnson (NYSE: JNJ  ) hit a new all-time high yesterday and have continued upward today, despite some negative news for the company last night. It was denied FDA approval for the acute coronary syndrome indication of its blood thinning drug Xarelto.

In this video, Motley Fool health-care bureau chief Brenton Flynn tells investors why this highlights a very difficult and very expensive trend for Big Pharma, but also points out that a company as large and diversified as Johnson & Johnson can weather the blow much more easily than some of the smaller players.

Is bigger really better?
Involved in everything from baby powder to biotech, Johnson & Johnson's critics are convinced that the company is spread way too thin. If you want to know if J&J is nothing but a bloated corporate whale -- or a well-diversified giant that's perfect for your portfolio -- check out the Fool's new premium report outlining the Johnson & Johnson story in terms that any investor can understand. Claim your copy by clicking here now.


Read/Post Comments (2) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 06, 2013, at 9:46 AM, marytormey wrote:

    J&J has bad ethics, the lawsuits and recalls are far from over.

  • Report this Comment On March 07, 2013, at 10:12 AM, chopchop0 wrote:

    The market hasn't seem to care about the lawsuits or recalls. The stock just keeps printing new highs.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2295114, ~/Articles/ArticleHandler.aspx, 10/25/2014 5:08:46 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement